Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Skye Bioscience Inc (SKYE)

Skye Bioscience Inc (SKYE)
1.4300 -0.1500 (-9.49%) 15:21 ET [NASDAQ]
1.4200 x 105 1.4400 x 222
Realtime by (Cboe BZX)
1.4200 x 105 1.4400 x 222
Realtime 1.6300 +0.0500 (+3.16%) 09:28 ET
News & Headlines for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News

The broader market experienced mixed performance to start the week, with major indices showing volatility but ultimately closing higher. On Monday, Dow Jones Industrial Average (DJI) gained 0.78%. The...

JNVR : 51.50 (-28.55%)
SKYE : 1.4300 (-9.49%)
AVTE : 2.75 (+2.61%)
RXRX : 5.40 (+1.50%)
CERT : 14.04 (+3.77%)
^SOLUSD : 133.1572 (+1.09%)
UAMY : 3.14 (-10.03%)
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News

SKYE : 1.4300 (-9.49%)
JNVR : 51.50 (-28.55%)
AVTE : 2.75 (+2.61%)
RXRX : 5.40 (+1.50%)
CERT : 14.04 (+3.77%)
UAMY : 3.14 (-10.03%)
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News

The broader market experienced mixed performance on Monday, with major indices showing volatility but ultimately closing higher. The Dow Jones Industrial Average gained 0.78%. The S&P 500 rose 0.79%, and...

JNVR : 51.50 (-28.55%)
SKYE : 1.4300 (-9.49%)
AVTE : 2.75 (+2.61%)
RXRX : 5.40 (+1.50%)
CERT : 14.04 (+3.77%)
UAMY : 3.14 (-10.03%)
Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model

SKYE : 1.4300 (-9.49%)
Skye Bioscience to Conduct Meetings at Piper Sandler Conference

SKYE : 1.4300 (-9.49%)
Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

SKYE : 1.4300 (-9.49%)
Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025

SKYE : 1.4300 (-9.49%)
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SKYE : 1.4300 (-9.49%)
Is This Penny Stock’s 525% Upside Potential an Attainable Goal?

Skye Bioscience is trying to establish a presence in the weight-loss drug market.

SKYE : 1.4300 (-9.49%)
NVO : 58.14 (-7.54%)
$SPX : 5,300.43 (+0.47%)
LLY : 848.00 (+15.39%)
Skye Bioscience to Participate in SXSW Session on Obesity

SKYE : 1.4300 (-9.49%)

Barchart Exclusives

Is Silver Back on a Bullish Path?
Silver is twice as volatile as gold, making it a highly speculative asset. In March, silver prices looked like they were heading for a test of the 2011 and 1980 highs, but April has been another story. Silver’s exclusion from tariffs caused a tidal wave of selling from April 2 through April 7. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro